CDSCO monthly lab alert
CDSCO NSQ alert, January 2025: 145 drug batches flagged
By Blacklisted editorial team· Published 20 Feb 2025· Updated 3 Nov 2026· Source: CDSCO NSQ portal
In its January 2025 alert, the Central Drugs Standard Control Organisation listed 145 drug batches that failed quality tests, 52 at central laboratories and 93 at state drug-testing laboratories, from 101 manufacturers across 111 products. The most common failure was assay, and the most-represented manufacturing state was Himachal Pradesh. Products flagged include Compound Sodium Lactate Injection I.P (Ringer?s Lactate I.P), Gentamicin Injection IP- 2ml, Mupirocin Ointment IP.
145
Batches flagged
52 / 93
Central / state labs
Assay
Top reason
101
Manufacturers
Batches per month, last 12 alerts
Feb 2024Jan 2025 · 145
Full list of NSQ batches, January 2025
Download CSV| Product | Batch | Manufacturer | Reason declared NSQ | Tested by |
|---|---|---|---|---|
| Zinc Sulphate Dispersible Tablets IP 20 mg | Batch LMT240811Mfg Jul 2024 · Exp Jun 2026 | Life Max Cancer Laboratories | Uniformity of dispersion & DisintegrationDisintegration | RDTL GuwahatiCDSCO lab |
| Xputum-LS Syrup | Batch 24-XLS-, 010Mfg Feb 2024 · Exp Jul 2025 | Stedman Pharmaceuticals Pvt Ltd | Sample does not conform to Label Claim With respect to content of Levosalbutamol in Levosalbutamol Sulphate.Labelling | DTL MaduraiState lab |
| Vitamin B- Complex with Vitamin C and Zinc Capsules (Nutribest-Plus) | Batch 1724-226Mfg May 2024 · Exp Oct 2025 | Zee Laboratories LtdHimachal Pradesh | Assay of 'Cyanocobalami n' and 'Calcium Pantothenate'Assay | CDL KolkataCDSCO lab |
| Vitamin B Complex Tablets NFI | Batch S0016/24, -25Mfg ? · Exp ? | Kerala Medical Services Corporation LtdKerala | The sample does not conform to IP standards with respect to ?Descriptive Part? for tablets.Other | DTL ThiruvananthapuramState lab |
| VIP Hair Colour Shampoo | Batch B107CMfg Jun 2024 · Exp May 2026 | VimacTamil Nadu | Sample does not conform to BIS specification for oxidation hair dye with respect to the content of phenyl methyl pyrazolone and ResorcinolOther | DTL ChennaiState lab |
| Tuclav -CV 625[ Amoxycillin and Potassium Clavulanate Tab IP | Batch MYRTAB, -618Mfg Aug 2024 · Exp Jan 2026 | Mayer LabHimachal Pradesh | It fails the test Dissolution and Assay as per IPAssay | DTL ThiruvananthapuramState lab |
| Ttocin Ointment, Mupirocin with Tea Tree Oil Ointment | Batch MVO-070Mfg Oct 2024 · Exp Sep 2026 | Bonn Schetering Bio SciencesPuducherry | Sample does not conform to label claim with respect to the content of mupirocin.Labelling | DTL ChennaiState lab |
| Tramadol Hydrochloride Injection 50 mg/ml (Tramacop) | Batch RP-04Mfg Jul 2023 · Exp Jun 2025 | Bio Medica Laboratories Pvt. LtdMadhya Pradesh | 'Acidity or Alkalinity' and 'Assay of Tramadol'Assay | CDL KolkataCDSCO lab |
| Ticagrelor Tablets IP 90 mg (Tigamon 90) | Batch MT230087Mfg Nov 2023 · Exp Oct 2026 | Monique Pharmaceutical S Pvt. LtdHaryana | DissolutionDissolution | CDL KolkataCDSCO lab |
| Thiamine Hydrochlori de Tablets IP 100mg (KTHAMINE -100) | Batch ZRST- 1361Mfg Aug 2024 · Exp Jan 2026 | ZRS Pharmaceuticals India Pvt. LtdHimachal Pradesh | (i) On the received sample, Presence of Spot defect was observed which should not be present as per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discoloration. (ii)The label of the container in the drug is mentioned as 'Approved colour used' but the common name of the permitted colour used in the formulation as prescribed under rule 127 (2) of the drug rule was not mentioned. (iii) The label claim of the drug states 'Thiamin hydrochloride IP 100mg' instead of ' Thiamine Hydrochoride IP 100mg' but the proper name of the drug should be written as prescribed under 96(1),(i)(A) of The Drugs and Cosmetics Act. (iv) The label claim of the received sample states Thiamin Hydrochloride IP 100mg whereas in the IP monograph, The usual strength of the thiamine tablet is stated as 5mg, 10mg, 50mg. Hence,the Strength of the sample received does not match the usual strength as mentioned in the IP monograph. - NSQLabelling | State Lab PuducherryState lab |
| TELMA AM | Batch 5240367Mfg Mar 2024 · Exp Feb 2027 | Under Investigation | Does not confirm to I.P.Other | SDTL KolkataState lab |
| Sucralfate and Oxetacain Suspension | Batch SEL2401Mfg Jan 2024 · Exp Dec 2025 | CU-V-Kar Genetic Medicines Pvt LtdUttarakhand | Sample does not conform to Label claim with respect to content of Oxetacaine.Labelling | DTL MaduraiState lab |
| Sucnol-O Suspension | Batch SCI-2305Mfg Nov 2023 · Exp Oct 2025 | Apple Formulations Pvt. LtdUttarakhand | Sample does not conform to Label Claim with respect to the content of OxetacaineLabelling | DTL MaduraiState lab |
| Spironolacto ne Tablets IP | Batch T- 2403993Mfg Mar 2024 · Exp Feb 2026 | Oscar Remedies Pvt. Ltd | Sample does not conform to IP specification for Spironolactone Tablets with respect to DissolutionDissolution | DTL ChennaiState lab |
| Sodium Chloride and Glycerine Sterile Diluent for fowl pox vaccine and its combinations for wing web application | Batch ACF24159Mfg Nov 2024 · Exp Oct 2026 | Safe Parenterals Pvt. Ltd. Gollapadu 522408Andhra Pradesh | Description, Appearance of solution and Particulate matterDescription | CDL KolkataCDSCO lab |
| Retibak (0.2% Retinol) Face Serum | Batch AHO2400 48Mfg Jul 2024 · Exp ? | Mfg By: M/s. Aarohee healthcare Private LtdKarnataka | NOT OF STANDARD QUALITY Sample does not meets the specifications wrt. To identification test for Retinol as per STP.Identification | State Lab Drugs Control Laboratory, TelanganaState lab |
| Ramipril Tablets IP 5 mg | Batch TPT- 0102040Mfg ? · Exp ? | Tanpal Pharmaceuticals | Assay of RamiprilAssay | RDTL ChandigarhCDSCO lab |
| Rabeprazole Sodium Injection I.P. | Batch MD23H13Mfg Aug 2023 · Exp Jul 2025 | Martin & Brown Bio-Sciences Pvt. LtdHimachal Pradesh | pH, Water, Clarity of Solution, Particulate matter and Assay of Rabeprazole SodiumAssay | CDL KolkataCDSCO lab |
| Rabeprazole Sodium 20mg (EC) & Domperidone 10mg (IR), Domperidone 20mg (SR) Capsules (Rebast-ARD) | Batch LC-6943Mfg Jan 2024 · Exp Dec 2025 | Lifevision HealthcareHimachal Pradesh | DissolutionDissolution | RDTL GuwahatiCDSCO lab |
| Rabeprazole Sodium (as enteric coated) & Domperidone (As Sustained Release) Capsules (Rabito-DSR) | Batch RTD.23010 5Mfg Aug 2023 · Exp Jul 2025 | Cartel LaboratoriesTelangana | Assay of Rabeprazole SodiumAssay | RDTL GuwahatiCDSCO lab |
| Pyridoxine Tablets IP 10 mg (Pyrotan-10) | Batch TPT- 0102064Mfg ? · Exp ? | Tanpal Pharmaceuticals | Assay of PyridoxineAssay | RDTL ChandigarhCDSCO lab |
| Pregabalin (SR) & Methylcobal amin Tablet (Mecoben ? PG) | Batch MP - 240724Mfg Oct 2024 · Exp Sep 2026 | Medistark Biotech Pvt. Ltd. R.S.No. 68/4 | The label of the container in the drug is mentioned as 'Approved colour used' but the common name of the permitted colour used in the formulation as prescribed under rule 127 (2) of the drug rule was not mentioned. - MisbrandedMisbranded | State Lab PuducherryState lab |
| Povinanz Gargle | Batch ES40030Mfg Mar 2024 · Exp Feb 2026 | Nanz med Science Pharma Pvt LtdHimachal Pradesh | sample does not conform to label with respect to the content of available iodine in povidone-iodineLabelling | DTL ChennaiState lab |
| Podine-M | Batch PM 04Mfg Apr 2024 · Exp Mar 2026 | Karlin Pharmaceuticals & Exports Private LimitedTamil Nadu | sample does not conform to label claim with respect to the content of available iodine in povidone iodineLabelling | DTL ChennaiState lab |
| Parenteral preparations, Piperacillin & Tazobactam Injection I.P. 4.5 gm | Batch 24PT41Mfg ? · Exp ? | Mfg By: Sai parenterals limited D1&D4Telangana | NOT OF STANDARD QUALITY Test for sterility does not complies as per IP for the sample Piperacillin and Tazobactam injection IP 4.5 gmSterility | State Lab Drugs Control Laboratory, TelanganaState lab |
| Paradolo 500 [Paracetam ol Tab IP 500 mg] | Batch AGT4055 4Mfg May 2024 · Exp Apr 2027 | Alventa Pharma LtdHimachal Pradesh | It fails the test ?Dissolution? as per IPDissolution | DTL ThiruvananthapuramState lab |
| Paracetamol Oral Suspension BP (100 ml) 120 mg/ 5 ml | Batch ZA23019Mfg Jul 2023 · Exp Jun 2026 | Brussels Laboratories Pvt. LtdGujarat | Assay of ParacetamolAssay | CDTL MumbaiCDSCO lab |
| Paracetamo l, Phenylephri ne HCl, Caffeine & Diphenhydr amine HCl Tablets (CINKOLD) | Batch SG034B0 3Mfg Feb 2023 · Exp Jan 2025 | Sharun Pharmaceuticals Pvt.LtdPuducherry | NOTE:(i) On the received sample, Presence of Spot defect was observed which should not be present as per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discoloration. (ii)The label of the container in the drug is mentioned as 'Approved colour used' but the common name of the permitted colour used in the formulation as prescribed under rule 127 (2) of the drug rule was not mentioned. vel - NSQLabelling | State Lab PuducherryState lab |
| Paracetamo l, Cetirizine Hydrochlori de & Phenylephri ne Hydrochlori de Tablets (WINCOLD Z) | Batch WNZT- 3240Mfg Nov 2023 · Exp Oct 2026 | Wings Biotech LLPHimachal Pradesh | On the received sample presence of spots were observed which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discoloration - NSQDescription | State Lab PuducherryState lab |
| Pantoprazol e tablets IP | Batch P03524Mfg ? · Exp ? | Mfg By: Spansules formulations India Pvt.LtdTelangana | NOT OF STANDARD QUALITY Assay and Dissolution test does not complies for Pantoprazole tablets as per IP 2022.Assay | State Lab Drugs Control Laboratory, TelanganaState lab |
| PC-WIN- 650 | Batch VGT2316 99CMfg Sep 2023 · Exp Aug 2025 | Mfg By: Vrindavan GlobalHimachal Pradesh | The sample does not conform to IP 2022 with respect to the test for DissolutionDissolution | Drug Testing Laboratory Srinagar (J&K) vide report on Form 13 bearing No. L/DA/2024-25/1593 Dated: 29.10.2024. (Report attached as Annexure A)State lab |
| Ondem-4 [Ondansetro n Tablets IP] | Batch 2444145, 1Mfg Apr 2024 · Exp Mar 2026 | Alkem Health ScienceSikkim | It fails the test dissolution specified in the Laboratory Protocol as per IPDissolution | DTL ThiruvananthapuramState lab |
| Ondansetro n orally disintegratin g tablets IP 4 mg | Batch T-15842Mfg ? · Exp ? | Mfg By: Karnani Pharmaceuticals Pvt.LtdUttarakhand | NOT OF STANDARD QUALITY While opening the strip, it is found that the tablets are not in intact condition. Received 50 tablets, out of 50 tablets, 40 tablets are not in intact condition. Hence sample is of Not of Standard Quality with respect to Description test parameter.Description | State Lab Drugs Control Laboratory, TelanganaState lab |
| Ofloxacin Ophthanmic Solution IP (Ocuex Eye Drops) | Batch ED4648Mfg Nov 2024 · Exp Oct 2026 | Captab BiotecHimachal Pradesh | Assay of OfloxacinAssay | CDL KolkataCDSCO lab |
| Ofloxacin & Ornidazole Tablets IP (Zeof-O) | Batch SCZAG230 07Mfg Jun 2023 · Exp Nov 2025 | Sano-Cito Therapeutics IncHimachal Pradesh | DissolutionDissolution | CDL KolkataCDSCO lab |
| Nyomi Fruit Vinegar Black Hair Gel Colour | Batch 2024071, 2Mfg Jul 2024 · Exp Jul 2027 | Guangzhou Aocai Bio- Technology Co. Ltd | Sample does not conform to BIS Specification for Oxidation Hair dye with respect to the content of Phenyl Methyl Pyrazole.Other | DTL ChennaiState lab |
| Nozal Cream | Batch 3447Mfg Mar 2024 · Exp Feb 2026 | Olcare Laboratories | Sample does not conform to BP Specification for Ketoconazole Cream with respect to the content of Ketoconazole.Other | DTL ChennaiState lab |
| Nozal | Batch 4246Mfg Oct 2024 · Exp Sep 2026 | Olcare Laboratories | Sample does not conform to BP Specification for Ketoconazole cream with respect to the content of KetoconazoleOther | DTL ChennaiState lab |
| Norfloxacin Tablets IP 400mg | Batch RNFT- 014Mfg ? · Exp ? | Mfg By: Revat Laboratories Pvt.LtdAndhra Pradesh | NOT OF STANDARD QUALITY Dissolution test does not complies for Norfloxacin Tablets IP at S2 level as per IP 2022.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab |
| Norfloxacin Tablets IP 400mg | Batch RNFT- 017Mfg ? · Exp ? | Mfg By: Revat Laboratories Pvt.LtdAndhra Pradesh | NOT OF STANDARD QUALITY Dissolution test does not complies for Norfloxacin Tablets IP at S2 Level as per IP 2022.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab |
| Non-Sterile Not for Intravenous Administration Concentrated Acidic Solution | Batch BT229Mfg Jul 2024 · Exp Jun 2025 | Bio Tech FormulationAndhra Pradesh | Appearance of solution, assay of sodium, potassium, calcium, magnesium and total chloride. Particulate contamination and descriptionAssay | CDL KolkataCDSCO lab |
| Nimesulide & Paracetamol Tablets (SOMOO) | Batch T-24004Mfg Apr 2024 · Exp Mar 2026 | Kshipra Drugs Pvt. Ltd | DisintegrationDisintegration | RDTL GuwahatiCDSCO lab |
| N-Clin Gel | Batch M030Mfg Jul 2024 · Exp Jun 2026 | Elegant Cosmed Pvt LtdGujarat | Sample does not conform to label claim with respect to the content Clindamycin in Clindamycin PhosphateLabelling | DTL ChennaiState lab |
| Mupirocin Ointment IP 2% w/w | Batch NO33015 6Mfg Nov 2023 · Exp Oct 2025 | Nanz med Science Pharma Pvt LtdHimachal Pradesh | Sample does not conform to IP specification for Mupirocin Ointment with respect to the content of mupirocinOther | DTL MaduraiState lab |
| Mupirocin Ointment IP | Batch DC2437Mfg Mar 2024 · Exp Aug 2025 | Arius Formulation Private Limited | Sample does not conform to IP Specification for Mupirocin Ointment with respect to the content of MupirocinOther | DTL MaduraiState lab |
| Mupirocin Ointment IP | Batch ME-41Mfg Feb 2024 · Exp Jan 2026 | Maxwell pharmaHimachal Pradesh | Sample does not conform to IP specification for Mupirocin Ointment with respect to identification and content of mupirocinIdentification | DTL MaduraiState lab |
| Mupirocin Ointment IP | Batch SO-033Mfg Mar 2024 · Exp Feb 2026 | SB Lifesciences pvt ltdHimachal Pradesh | Sample does not conform to IP specification for Mupirocin Ointment with respect to the content of MupirocinOther | DTL MaduraiState lab |
| Montelukast Sodium and Levocetirizine Hydrochloride Dispersible Tablets (ROMILAST� L 4) | Batch 18RT2401Mfg Apr 2024 · Exp Sep 2026 | Adnova Healthcare Pvt. Ltd. 156Gujarat | Description and Uniformity of dispersionDescription | CDTL IndoreCDSCO lab |
| Montelukast & Levocetirizine Hydrochloride Tablets IP (SOLIKAST-L) | Batch VLB-GT- 2219Mfg Sep 2023 · Exp Aug 2025 | Vee LaboratoriesHimachal Pradesh | DissolutionDissolution | RDTL GuwahatiCDSCO lab |
| Monopropylene Glycol USP | Batch 9971702044Mfg Apr 2024 · Exp Apr 2026 | Shell Eastern Chemicals | WaterWater content | CDL KolkataCDSCO lab |
| Mobicool TM-S Suspenion | Batch RL- 231203Mfg Feb 2024 · Exp Jan 2026 | Rednex PharmaceuticalsGujarat | Sample does not conform to Label claim with respect to content OxetacaineLabelling | DTL MaduraiState lab |
| Metoprolol Succinate Prolonged Release Tablets IP 25 mg | Batch DT 2403Mfg ? · Exp Sep 2027 | Triveni Formulations Limited | DissolutionDissolution | CDTL HyderabadCDSCO lab |
| Metoprolol Succinate Extended Release & Telmisartan Tablets (Leaftel Beta ? 25) | Batch MP - 231584Mfg Mar 2024 · Exp Feb 2026 | Medistark Biotech Pvt. Ltd | The label of the container in the drug is mentioned as 'Approved colour used' but the common name of the permitted colour used in the formulation as prescribed under rule 127 (2) of the drug rule was not mentioned. - MisbrandedMisbranded | State Lab PuducherryState lab |
| Metoclopramide Injection BP | Batch 4EC038092Mfg Aug 2024 · Exp Jul 2027 | Ciron Drugs & Pharmaceuticals Pvt. LtdMaharashtra | Description and Particulate ContaminationDescription | CDL KolkataCDSCO lab |
| Metformin Hydrochloride Sustained Release Tablets I.P. 500mg (Conmet SR- 500) | Batch C21D93400 3Mfg Jun 2024 · Exp May 2027 | Concept Pharmaceuticals Ltd | DissolutionDissolution | CDL KolkataCDSCO lab |
| Mecobalami n Sublingual Tablets 1500 mcg (Re- Xite BTX) | Batch D240601 9Mfg Jun 2024 · Exp May 2026 | Linux Life Sciences Pvt LtdPuducherry | On the received sample, Presence of Spot defect was observed which should not be present as per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discoloration.- NSQDescription | State Lab PuducherryState lab |
| Luliconazole Cream IP 1% w/w | Batch 2946Mfg May 2024 · Exp Apr 2026 | Regent Ajanta BiotechUttarakhand | sample does not Conform to IP Specification for Luliconazole Cream with respect to the PH of 10% w/v solution.pH | DTL MaduraiState lab |
| Lukus | Batch G198Mfg Jun 2024 · Exp May 2026 | INDKUS Biotech IndiaHimachal Pradesh | Sample does not conform to IP specification for Luliconazole Cream with respect to the content of LuliconazoleOther | DTL MaduraiState lab |
| Lucos-LM kid suspension | Batch AMS2341 6Mfg Dec 2023 · Exp Nov 2025 | Alop Med-Sciences Pvt LtdHimachal Pradesh | Sample does not conform to Label claim with respect to the content of Levocetirizine Hydrochloride and Montelukast in Montelukast Sodium.Labelling | DTL ChennaiState lab |
| Losartan Tablets IP 50 mg | Batch LMT240826Mfg Jul 2024 · Exp Jun 2026 | Life Max Cancer Laboratories | DissolutionDissolution | RDTL GuwahatiCDSCO lab |
| Losartan Potassium Tab IP 25 mg | Batch D 2615/24-, 25Mfg ? · Exp ? | Kerala Medical Services Corporation LtdKerala | It fails the ?Descriptive Part? for the tablets as per IP, tablets should have sufficient hardness for handling without crumbling and breakingOther | DTL ThiruvananthapuramState lab |
| Lorazepam Tablets IP 1 mg (PROLINE - 1) | Batch 06P23T03Mfg Aug 2023 · Exp Apr 2027 | Shine Pharmaceuticals LimitedGujarat | AssayAssay | CDTL MumbaiCDSCO lab |
| Liquid Paraffin IP 400 ml | Batch HP 24002Mfg Jul 2024 · Exp Jun 2026 | Multicure Pharma Private LimitedTelangana | It fails the tests ?Weight per ml and ?Light Absortion? as per IPWeight | DTL ThiruvananthapuramState lab |
| Levocetirizine Hydrochloride & Montelukast Sodium Tablets IP (Montura-L) | Batch ZT23547CMfg Nov 2024 · Exp Oct 2025 | Zenon Lifesciences Pvt. LtdGujarat | Dissolution of MontelukastDissolution | RDTL GuwahatiCDSCO lab |
| Ketoya Soap | Batch MO26Mfg Aug 2024 · Exp Jul 2026 | Elegant Cosmed Pvt LtdGujarat | sample does not conform to label claim with respect to the content of KetoconazoleLabelling | DTL ChennaiState lab |
| Kaltfer Drops Iron(III)- Hydroxide Polymaltose Complex Drops. | Batch EHL- 3532Mfg ? · Exp ? | Mfg By: M/s. Exotic HealthcarePunjab | NOT OF STANDARD QUALITY The sample Does not meets the Specifications wrt. Identification Test - Negative, Assay - Nil as per STP. U/S. 17 B of Drugs and Cosmetics Act 1940. The Sample deemed to be Spurious Drug.Assay | State Lab Drugs Control Laboratory, TelanganaState lab |
| Itraconazole Capsules IP 100 mg | Batch CTA-01Mfg Feb 2024 · Exp Jan 2026 | Agron Remedies Pvt. LtdUttarakhand | DissolutionDissolution | RDTL GuwahatiCDSCO lab |
| Itraconazole Capsules (Trax - 200) | Batch AFC - 102Mfg May 2024 · Exp Apr 2026 | Apex Formulations Pvt. LtdGujarat | DissolutionDissolution | CDTL MumbaiCDSCO lab |
| Iron Sucrose Injection USP 100mg/5ml | Batch 24RS04Mfg Jan 2024 · Exp Dec 2025 | SAI Parenterals LimitedTelangana | pHpH | CDL KolkataCDSCO lab |
| Iron Sucrose Injection USP 100mg/5ml | Batch 24RS08Mfg Feb 2024 · Exp Jan 2026 | SAI Parenterals LimitedTelangana | pHpH | CDL KolkataCDSCO lab |
| Hyoscine Butylbromide Tablets IP (BUSCOPRIME -10 TABLETS) | Batch PT-102441Mfg Oct 2024 · Exp Sep 2026 | Primus PharmaceuticalsHimachal Pradesh | Assay of Hyoscine ButylbromideAssay | RDTL ChandigarhCDSCO lab |
| HYPODERMIC SYRINGE WITH NEEDLE (Nusafe 2ml) | Batch 2407154Mfg Jul 2024 · Exp Jun 2029 | Nubeno Healthcare Private LimitedMaharashtra | SterilitySterility | RDTL GuwahatiCDSCO lab |
| Glimepiride Tablet IP 1 mg | Batch D2721/24, -25Mfg ? · Exp ? | Kerala Medical Services Corporation LtdKerala | The sample does not conform to IP standards with respect to ?Descriptive Part? for tablets.Other | DTL ThiruvananthapuramState lab |
| Glimepiride Tablet IP 1 mg | Batch D2505/24, -25Mfg ? · Exp ? | Kerala Medical Services Corporation LtdKerala | It fails the test dissolution and ?Descriptive Part? specified in the Laboratory Protocol as per IPDissolution | DTL ThiruvananthapuramState lab |
| Glimepiride Tablet IP | Batch D2854/24, -25Mfg ? · Exp ? | Kerala Medical Services Corporation LtdKerala | The sample does not conform to IP standards with respect to ?Descriptive Part? for tablets.Other | DTL ThiruvananthapuramState lab |
| Gentamicin Injection IP- 2ml | Batch HLI615FMfg Jun 2024 · Exp May 2026 | Himalaya Meditek Pvt. LtdUttarakhand | sample does not Conform to the requirement for PHpH | King Institute ChennaiState lab |
| Gentamicin Injection IP- 2ml | Batch HLI623FMfg Jun 2024 · Exp May 2026 | Himalaya Meditek Pvt. LtdUttarakhand | sample does not Conform to the requirement for PHpH | King Institute ChennaiState lab |
| Gentamicin Injection IP- 2ml | Batch HLI628FMfg Jun 2024 · Exp May 2026 | Himalaya Meditek Pvt. LtdUttarakhand | sample does not Conform to the requirement for PHpH | King Institute ChennaiState lab |
| Gentamicin Injection IP- 2ml | Batch 24BUF83Mfg Jun 2024 · Exp May 2026 | SVP Life scienceUttarakhand | sample does not Conform to the requirement for PHpH | King Institute ChennaiState lab |
| Gentamicin Injection IP- 2ml | Batch 24BUE74Mfg May 2024 · Exp Apr 2026 | SVP Life SciencesUttarakhand | Sample does not conform to the requirement for PH.pH | King Institute ChennaiState lab |
| Gentamicin Injection IP- 2ml | Batch HLI620FMfg Jun 2024 · Exp May 2026 | Himalaya Meditek Pvt. LtdUttarakhand | sample does not Conform to the requirement for PHpH | King Institute ChennaiState lab |
| Gentamicin Injection IP- 2ml | Batch 23BUH50Mfg Aug 2023 · Exp Jul 2025 | SVP Life scienceUttarakhand | sample does not Conform to the requirement for PHpH | King Institute ChennaiState lab |
| Gentamicin Injection I.P. 30 ml | Batch GM-19Mfg Apr 2024 · Exp Mar 2026 | New Lab IndustryBihar | SPURIOUS Particulate Matter, Extractable Volume, Composition of Gentamicin Sulphate, Identification and Assay of Gentamicin Sulphate and DescriptionAssay | CDL KolkataCDSCO lab |
| Flumethrin 1% Porur- On Solution | Batch EE- 240906Mfg Sep 2024 · Exp Aug 2026 | Ethicare LaboratoriesJammu & Kashmir | Sample does not conform to Lablel Claim with respect to the content of Flumethrin.Other | DTL MaduraiState lab |
| Fexofenadine Hydrochloride Tablets I.P. 120 mg. | Batch UGT231163Mfg Aug 2023 · Exp Jul 2025 | Unimarck Healthcare LtdUttarakhand | DissolutionDissolution | RDTL GuwahatiCDSCO lab |
| Fexofenadin e Hydrochlori de Tab IP 180 mg [Fexodil- 180] | Batch T 3105Mfg Oct 2024 · Exp Sep 2026 | Jackson Laboratories Pvt. LtdPunjab | It fails the test ?Dissolution? as per IPDissolution | DTL ThiruvananthapuramState lab |
| Enteric Coated Rabeprazole Sodium And Domperidone Sustained Release Capsules (Dorab SR Capsules) | Batch AFC - 111Mfg Aug 2024 · Exp Jul 2026 | Apex Formulations Pvt. LtdGujarat | Dissolution for DomperidoneDissolution | CDTL MumbaiCDSCO lab |
| Dmex Colecalciferol (Vitamin D3) Tablets B.P. | Batch 4D077301Mfg Sep 2023 · Exp Aug 2026 | Aeron Lifesciences Pvt LtdGujarat | Assay of CholecalciferolAssay | CDL KolkataCDSCO lab |
| Diclofenac Sodium Injection IP (AL- DICLO) | Batch A-1694Mfg Feb 2024 · Exp Jan 2026 | Alchemist Remedies Pvt. Ltd | pH, Sterility, Particulate Matter, and AssayAssay | RDTL GuwahatiCDSCO lab |
| Diclofenac Sodium Injection I.P (DEPAIN-75) | Batch SNDA23801Mfg Aug 2023 · Exp Jul 2025 | Srinija Parenterals | pHpH | CDL KolkataCDSCO lab |
| Dexamethasone Sodium Phosphate Injection (Dexamethason e 30ml) | Batch DX-18Mfg Apr 2024 · Exp Mar 2026 | New Lab IndustryBihar | SPURIOUS pH, Extractable volume, Particulate matter, Sterility, Identification and Assay of Dexamethasone Sodium Phosphate and DescriptionAssay | CDL KolkataCDSCO lab |
| Cumox 500 | Batch FDCX- 076Mfg Oct 2024 · Exp Sep 2026 | Firstmed Therapeuticals pvt ltd | Sample does not conform to IP specification for Amoxycillin capsules with respect to Uniformity of Weight and to the content of Amoxycillin in Amoxycillin Trihydrate.Uniformity of weight/content | DTL ChennaiState lab |
| Coscopin Cold Plus | Batch CSP2300 1Mfg Jun 2023 · Exp May 2025 | Windlas Biotech Limited (Plant-2)Uttarakhand | Sample does not conform to Label claim with respect to the content of Phenylephrine HydrochlorideLabelling | DTL MaduraiState lab |
| Compound Sodium Lactate Injection I.P (Ringer?s Lactate I.P) | Batch 03BF226, 0Mfg Oct 2023 · Exp Sep 2026 | Paschim Banga Pharmaceuticals | Test for SterilitySterility | State Lab KarnatakaState lab |
| Compound Sodium Lactate Injection I.P (Ringer?s Lactate I.P) | Batch 03BP012, 0Mfg Jan 2024 · Exp Dec 2026 | Paschim Banga Pharmaceuticals | Test for SterilitySterility | State Lab KarnatakaState lab |
| Compound Sodium Lactate Injection I.P (Ringer?s Lactate I.P) | Batch 03BP011, 5Mfg Dec 2023 · Exp Nov 2026 | Paschim Banga Pharmaceuticals | Test for Sterility and Bacterial Endotoxins TestSterility | State Lab KarnatakaState lab |
| Compound Sodium Lactate Injection I.P (Ringer?s Lactate I.P) | Batch 03BF231, 8Mfg Dec 2023 · Exp Nov 2026 | Paschim Banga Pharmaceuticals | Bacterial Endotoxins Test? and ?Test for SterilitySterility | State Lab KarnatakaState lab |
| Compound Sodium Lactate Injection I.P (Ringer?s Lactate I.P) | Batch 03BF225, 6Mfg Oct 2023 · Exp Sep 2026 | Paschim Banga Pharmaceuticals | Test for SterilitySterility | State Lab KarnatakaState lab |
| Compound Sodium Lactate Injection I.P (Ringer?s Lactate I.P) | Batch 03BF232, 9Mfg Dec 2023 · Exp Nov 2026 | Paschim Banga Pharmaceuticals | Bacterial Endotoxin Test? and ?Test for SterilitySterility | State Lab KarnatakaState lab |
| Compound Sodium Lactate Injection I.P (Ringer?s Lactate I.P) | Batch 03BF221, 0Mfg Sep 2023 · Exp Aug 2026 | Paschim Banga Pharmaceuticals | Test for SterilitySterility | State Lab KarnatakaState lab |
| Compound Sodium Lactate Injection I.P (Ringer?s Lactate I.P) | Batch 03BF234, 2Mfg Dec 2023 · Exp Nov 2026 | Paschim Banga Pharmaceuticals | Sterility Test?Sterility | State Lab KarnatakaState lab |
| Compound Sodium Lactate Injection I.P (Ringer?s Lactate I.P) | Batch 03BF225, 4Mfg Oct 2023 · Exp Sep 2026 | Paschim Banga Pharmaceuticals | Sterility TestSterility | State Lab KarnatakaState lab |
| Compound Sodium Lactate Injection I.P (Ringer?s Lactate I.P) | Batch 03BF236, 9Mfg Dec 2023 · Exp Nov 2026 | Paschim Banga Pharmaceuticals | Bacterial Endotoxin TestBacterial endotoxins | State Lab KarnatakaState lab |
| Compound Sodium Lactate Injection I.P (Ringer?s Lactate I.P) | Batch 03BP005, 7Mfg Sep 2023 · Exp Aug 2026 | Paschim Banga Pharmaceuticals | Test for SterilitySterility | State Lab KarnatakaState lab |
| Compound Sodium Lactate Injection I.P (Ringer?s Lactate I.P) | Batch 03BP006, 0Mfg Sep 2023 · Exp Aug 2026 | Paschim Banga Pharmaceuticals | Test for SterilitySterility | State Lab KarnatakaState lab |
| Compound Sodium Lactate Injection I.P (Ringer?s Lactate I.P) | Batch 03BF231, 9Mfg Dec 2023 · Exp Nov 2026 | Paschim Banga Pharmaceuticals | Bacterial Endotoxins TestBacterial endotoxins | State Lab KarnatakaState lab |
| Compound Sodium Lactate Injection I.P (Ringer?s Lactate I.P) | Batch 03BF238, 9Mfg Feb 2024 · Exp Jan 2027 | Paschim Banga Pharmaceuticals | Test for SterilitySterility | State Lab KarnatakaState lab |
| Compound Sodium Lactate Injection I.P (Ringer?s Lactate I.P) | Batch 03BF232, 8Mfg Dec 2023 · Exp Nov 2026 | Paschim Banga Pharmaceuticals | Bacterial Endotoxin Test? and ?Test for SterilitySterility | State Lab KarnatakaState lab |
| Compound Sodium Lactate Injection I.P (Ringer?s Lactate I.P) | Batch 03BF224, 1Mfg Oct 2023 · Exp Sep 2026 | Paschim Banga Pharmaceuticals | Test for SterilitySterility | State Lab KarnatakaState lab |
| Co- Trimoxazole Tablets IP 480mg | Batch MT402Mfg Jan 2024 · Exp Dec 2026 | Maxwell Lifescience Pvt LtdMaharashtra | Sample does not conform to IP Specification for Co- Trimoxazole Tablets with respect to Dissolution for Trimethoprim and SulphamethoxazoleDissolution | DTL ChennaiState lab |
| Clopidogrel Tablet I.P 75 mg (Maxgrel - 75) | Batch MDP - 309Mfg Jun 2024 · Exp May 2026 | Medinok Healthcare Pvt. LtdPuducherry | (i) On the received sample, Presence of Spot and discoloration defects were observed which should not be present as per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discoloration. (ii)The label of the container in the drug is mentioned as 'Approved colour used' but the common name of the permitted colour used in the formulation as prescribed under rule 127 (2) of the drug rule was not mentioned. (iii) On the received sample, The name of the manufacturer and as prescribed under 96 (1) (iv) of the Drugs and Cosmetics Act. (iv) On the received sample,the label details of the primary packing does not match with that of the secondary packing (Excipients ?q.s is not mentioned in primary packing)- NSQ the address of the premises of the manufacturer appears in an inconspicuous manner on the label whereas they should appear in a conspicuous mannerLabelling | State Lab PuducherryState lab |
| Clobazam Tablets IP 5 mg | Batch TPT-012058Mfg Jan 2024 · Exp Dec 2026 | Tanpal Pharmaceuticals | DissolutionDissolution | CDL KolkataCDSCO lab |
| Ciprofloxacin Injection IP | Batch LV4210Mfg Mar 2024 · Exp Feb 2026 | Captab BiotecHimachal Pradesh | In test of Lactic Acid per mg of CiprofloxacinOther | RDTL ChandigarhCDSCO lab |
| Cetirizine Syrup IP | Batch CE3010Mfg Sep 2023 · Exp Aug 2025 | Kerala State Drugs and Pharmaceuticals LtdKerala | It fails the test ?Assay? as per IPAssay | DTL ThiruvananthapuramState lab |
| Cetirizine Syrup IP | Batch CE 3008Mfg Sep 2023 · Exp Aug 2025 | Kerala State Drugs and Pharmaceuticals LtdKerala | It fails the test Assay and content of packaged dosage forms specified in the laboratory protocol as per IPAssay | DTL ThiruvananthapuramState lab |
| Cetirizine Syrup IP | Batch CE4019Mfg May 2024 · Exp Apr 2026 | Kerala State Drugs and Pharmaceuticals LtdKerala | It fails the tests Microbial contamination in non- sterile products as per IPMicrobial limits | DTL ThiruvananthapuramState lab |
| Cefuroxime Axetil Tablets IP 500 mg | Batch 4617001Mfg May 2024 · Exp Apr 2026 | Bengal Chemicals & Pharmaceuticals LtdWest Bengal | DissolutionDissolution | CDL KolkataCDSCO lab |
| Ceftriaxone Injection IP (Cefiglad-1 Injection) | Batch SRIJ240041Mfg Oct 2024 · Exp Sep 2026 | Systole Remedies Pvt. LtdHimachal Pradesh | Particulate matterParticulate matter | RDTL ChandigarhCDSCO lab |
| Cefpodoxim e Proxetil Tablets IP 200 MG (RIZDOX- 200) | Batch VCT/129Mfg Aug 2023 · Exp Jul 2025 | Vats Biotech Pvt. LtdHimachal Pradesh | On the received sample Discoloration,rough surface and picking defects were observed which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discoloration (iv)Picking and (vii)Rough surface. - NSQDescription | State Lab PuducherryState lab |
| Cefpodoxim e & Potassium Clavulanate Tablets | Batch BPT- 3003Mfg ? · Exp ? | Mfg By: Geenac PharmaUttarakhand | NOT OF STANDARD QUALITY The sample does not meets the Specifications wrt. Identification test - and Assay - for Cefpodoxime and Clavulanic Acid as per STP. U/S. 17 B of Drugs and Cosmetics Act 1940. The Sample is deemed to be Spurious Drug.Assay | State Lab Drugs Control Laboratory, TelanganaState lab |
| Cefixime and Lactic Acid Bacillus Tablets (CEFIZOC-200 LB TABLETS) | Batch BT-240511Mfg May 2024 · Exp Apr 2026 | A.N.D Healthcare LtdPunjab | Assay of Lactic Acid BacillusAssay | RDTL ChandigarhCDSCO lab |
| Cefixime & Ofloxacin Tablets (CEPHAFLU- 400) | Batch CT5853AMfg Mar 2024 · Exp Feb 2026 | J.M. LaboratoriesHimachal Pradesh | Assay of CefiximeAssay | CDL KolkataCDSCO lab |
| Cefixime & Lactic Acid Bacillus Dispersible Tablets | Batch MLS- 24506Mfg Jul 2024 · Exp Jun 2026 | Maskon Life Sciences Pvt. LtdUttarakhand | Sample does not conform to label claim with respect to the content of Anhydrous Cefixime in Cefixime TrihydrateLabelling | DTL MaduraiState lab |
| Calcium Gluconate Injection I.P. 10% w/v (REOCAL) | Batch CG-386Mfg Mar 2024 · Exp Feb 2026 | Rathi Laboratories (Hindustan) Pvt. LtdBihar | pH, Particulate matter, Sterility and DescriptionDescription | CDL KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets (VICTOCAL ? D3) | Batch MDP - 746Mfg Sep 2024 · Exp Aug 2026 | Medinok Healthcare Pvt. LtdPuducherry | The sample received is labelled as CALCIUM CARBONATE & VITAMIN D3 TABLETS, however CALCIUM CARBONATE & VITAMIN D3 TABLETS is an official IP monograph (2022) hence should be labelled as CALCIUM AND VITAMIN D3 TABLETS IP. - Label issueLabelling | State Lab PuducherryState lab |
| Calcium Aspartate, Calcium Orotate, Calcitriol, Minerals And Vitamins Tablets | Batch EZF-1989Mfg Jul 2024 · Exp Dec 2026 | Overseas Health Care Pvt. Ltd | Assay/content of 'Calcitriol' and 'Zinc'Assay | CDL KolkataCDSCO lab |
| Calcium 500 mg with Vitamin D3 250 IU Tablets IP | Batch LMT240431Mfg Apr 2024 · Exp Mar 2026 | Life Max Cancer Laboratories | Identification and Assay of Vitamin D3 and Dissolution of CalciumAssay | RDTL GuwahatiCDSCO lab |
| CLAVPARK -LB 625mg (Amoxycillin, Potassium Clavulanate & Lactic Acid Bacillus Tab) | Batch CHTJ426 0Mfg Oct 2024 · Exp Sep 2026 | Park PharmaceuticalsHimachal Pradesh | Does not confirm to claimOther | SDTL KolkataState lab |
| Betamethas one Valerate Ointment IP 0.1% w/w | Batch B76Mfg Aug 2024 · Exp Jul 2026 | Syndicate PharmaMadhya Pradesh | Sample does not conform to IP Specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone Valerate.Other | DTL ChennaiState lab |
| Betamethas one Valerate Oilment IP 0.1% w/w | Batch BO6Mfg May 2024 · Exp Apr 2026 | Syndicate PharmaMadhya Pradesh | Sample does not conform to IP specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone Valerate.Other | DTL ChennaiState lab |
| BETAHISTI NE DIHYDROC HLORIDE TABLETS IP (Betahox- 8) | Batch T-18946Mfg Feb 2023 · Exp Jan 2025 | Jackson Laboratories Pvt. Ltd | On the received sample presence of spots were observed which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discolouration. - NSQDescription | State Lab PuducherryState lab |
| B&B Beaute Blanc Hair Colour Conditioner Natural Black | Batch 2201202, 4Mfg Jan 2024 · Exp Jan 2027 | Gabt Co Ltd | The sample is found to contain m- phenylenediamine which must not form part of the conposition of cosmetics products as per BIS specification 4707 (Part 2): 2017, under Annex A (clauses 1,2 and 3.1), serial No.1198.Other | DTL ChennaiState lab |
| Aspirin Tablets | Batch TAS2301 0ALMfg Oct 2023 · Exp Sep 2025 | Hindustan Laboratories LimitedMaharashtra | Sample does not conform to IP Specification for Aspirin Tablets with respect to the content of Aspirin.Other | DTL MaduraiState lab |
| Amoxycillin Trihydrate Capsules (RIMOXIN) | Batch RIX-040Mfg Jan 2024 · Exp Dec 2025 | RIPPON LABORATORIES No.44Puducherry | The sample received is labelled as AMOXYCILLIN TRIHYDRATE CAPSULES, however AMOXYCILLIN TRIHYDRATE CAPSULES is an official IP monograph (2022) hence should be labelled as AMOXYCILLIN TRIHYDRATE CAPSULES IP.- Label issueLabelling | State Lab PuducherryState lab |
| Amoxycillin Dispersible Tablets IP 125 mg | Batch PGA24- 001Mfg Jan 2024 · Exp Dec 2025 | Pondchy PharmaceuticalsPuducherry | Sample does not conform to IP Specification for Dispersible Tablets with respect to uniformity of Dispersion and DisintegrationDisintegration | DTL ChennaiState lab |
| Amoxycillin Dispersible Tablets IP 125 mg | Batch PGA24- 006Mfg Aug 2024 · Exp Jul 2026 | Pondchy PharmaceuticalsPuducherry | Sample does not conform to IP Specification for Dispersible Tablets with respect to uniformity of Dispersion and DisintegrationDisintegration | DTL ChennaiState lab |
| Amlodipine Tablets IP 5 mg (Systogan-5) | Batch CT062Mfg Aug 2024 · Exp Jul 2026 | Ryzer Pharmaceutical Pvt. LtdGujarat | Related substancesRelated substances | CDTL MumbaiCDSCO lab |
| Ambroxol HCl, Guaiphenesin, Terbutaline Sulphate and Menthol Syrup (BRONKOREX AM Syrup) | Batch BALS-2005Mfg Nov 2023 · Exp Oct 2025 | Wings Novitas Healthcare LLPHimachal Pradesh | Assay of Ambroxol Hydrochloride and Terbutaline SulphateAssay | RDTL ChandigarhCDSCO lab |
| Ambroxol HCL, Levosalbutamol sulphate and Guaiphenesin Drops (Breath- LS Drops) | Batch HBD 2403Mfg Apr 2024 · Exp Mar 2026 | Hippo Labs Pvt. LtdTelangana | DescriptionDescription | CDL KolkataCDSCO lab |
| Albendazole Tablets IP 400 mg (Albendazole 400) | Batch T-3159Mfg Jan 2024 · Exp Dec 2025 | Jackson Laboratories Pvt. LtdPunjab | DissolutionDissolution | RDTL GuwahatiCDSCO lab |
| Aceclofenac, Paracetamol and Serratiopeptidas e Tablets (ST- SP Tablets) | Batch NBT- 240624Mfg Nov 2024 · Exp Oct 2026 | Soft Touch Pharmaceuticals India LtHimachal Pradesh | Assay of Aceclofenac and ParacetamolAssay | RDTL ChandigarhCDSCO lab |
| Aceclofenac and Thiocolchico side Tablets (Speronac - MR) | Batch P240502Mfg May 2024 · Exp Apr 2026 | ? Prosilio Pharmaceuticals Pvt. LtdPuducherry | On the received sample presence of spots were observed which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discoloration - NSQDescription | State Lab PuducherryState lab |
| Aceclofenac Tablets IP 100 mg | Batch T042304Mfg Nov 2023 · Exp Apr 2025 | Bengal Chemicals & Pharmaceuticals LtdHaryana | Related substances and Assay of AceclofenacAssay | CDTL MumbaiCDSCO lab |
| Aceclofenac & Drotaverine Hydrochlori de Tablets (100 mg/ 80 mg) | Batch PRT2401, -01Mfg Jan 2024 · Exp Dec 2025 | Regent Ajanta BiotechUttarakhand | DescriptionDescription | State Lab KarnatakaState lab |
| Aceclofenac, Paracetamo l and Chlorzoxazo ne Tablets (Megaceclo MR) | Batch AMT2407 160Mfg Jul 2024 · Exp Jun 2026 | Marine Medicare Pvt. LtdHimachal Pradesh | On the received sample presence of spots observed which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discoloration- NSQDescription | State Lab PuducherryState lab |
Check your medicine. Enter the batch number printed on the strip, bottle or carton to see whether it appears in this or any earlier alert. Check a batch number
Sources
- Regulator
- Regulator
Changelog
- 3 Nov 2026: table generated from the CDSCO NSQ portal export (145 rows). Revised CDSCO lists are diffed on each monthly rebuild.